View Section: Financials
Sinohealth Statements
23
Sinohealth Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-12-31
%
235.46
100
133
56.5
102.46
43.5
31.892
13.5
43.95
18.7
68.635
29.1
33.822
14.4
17.862
7.6
—
0
50.548
21.5
1.622
0.7
51.898
22
0.14
371.33
2022-06-30
%
121.21
100
64.558
53.3
56.651
46.7
28.52
23.5
33.821
27.9
58.112
47.9
-1.461
-1.2
6.408
5.3
—
0
3.926
3.2
-1.361
-1.1
3.86
3.2
0.009
450
2021-12-31
%
217.19
100
86.552
39.9
130.63
60.1
29.627
13.6
34.653
16
58.796
27.1
71.837
33.1
5.984
2.8
—
0
75.919
35
16.308
7.5
61.888
28.5
0.138
450
2021-06-30
%
106.98
100
44.975
42
62.006
58
24.084
22.5
34.296
32.1
47.438
44.3
14.568
13.6
4.888
4.6
—
0
19.61
18.3
7.243
6.8
16.925
15.8
0.038
450
View Section: Balance Sheet